Found: 174
Select item for more details and to access through your institution.
Nomogram for predicting survival of patients with diffuse large B-cell lymphoma.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 6, p. 2041, doi. 10.1007/s00277-024-05669-0
- By:
- Publication type:
- Article
Specific dermoscopic findings in glomeruloid haemangioma for diagnosis of POEMS syndrome.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 6, p. e518, doi. 10.1111/jdv.19712
- By:
- Publication type:
- Article
Involvement of cardiac glycosides targeting Na/K-ATPase in their inhibitory effects on c-Myc expression via its transcription, translation and proteasomal degradation.
- Published in:
- Journal of Biochemistry, 2024, v. 175, n. 3, p. 253, doi. 10.1093/jb/mvad085
- By:
- Publication type:
- Article
A novel T cell-redirecting anti-GPRC5D × CD3 bispecific antibody with potent antitumor activity in multiple myeloma preclinical models.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-55143-0
- By:
- Publication type:
- Article
Low‐dose fluconazole as a useful and safe prophylactic option in patients receiving allogeneic hematopoietic stem cell transplantation.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 3, p. 1, doi. 10.1002/cam4.6815
- By:
- Publication type:
- Article
Safety, pharmacokinetics, and efficacy of belantamab mafodotin monotherapy in Japanese patients with relapsed or refractory multiple myeloma: DREAMM-11.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 5, p. 596, doi. 10.1007/s12185-023-03652-5
- By:
- Publication type:
- Article
Laryngeal edema as a symptom of local cytokine release syndrome after BCMA-targeting CAR-T therapy for relapsed and refractory multiple myeloma.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 5, p. 647, doi. 10.1007/s12185-023-03633-8
- By:
- Publication type:
- Article
Risk factors associated with overall survival in patients with multiple myeloma following carfilzomib treatment: A retrospective study from a large claims database in Japan.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 19, p. 19361, doi. 10.1002/cam4.6457
- By:
- Publication type:
- Article
A retrospective analysis of clinical features and treatment outcome in 21 patients with immunoglobulin M-related light-chain amyloidosis in Japan: a study from the Amyloidosis Research Committee.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 4, p. 443, doi. 10.1007/s12185-023-03647-2
- By:
- Publication type:
- Article
Integrated analysis of phase 1a and 1b randomized controlled trials; Treg-targeted cancer immunotherapy with the humanized anti-CCR4 antibody, KW-0761, for advanced solid tumors.
- Published in:
- PLoS ONE, 2023, v. 18, n. 9, p. 1, doi. 10.1371/journal.pone.0291772
- By:
- Publication type:
- Article
Aberrant tryptophan metabolism leads to unfavorable outcomes in lenalidomide‐treated myeloma patients.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 3, p. 424, doi. 10.1002/hon.3108
- By:
- Publication type:
- Article
Anti‐CD38 antibody isatuximab monotherapy for Japanese individuals with relapsed/refractory multiple myeloma: An update of the phase 1/2 ISLANDs study.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 3, p. 442, doi. 10.1002/hon.3105
- By:
- Publication type:
- Article
Correction: Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00866-y
- By:
- Publication type:
- Article
Treatment pattern and clinical outcomes in multiple myeloma patients in Japan using the Medical Data Vision claims database.
- Published in:
- PLoS ONE, 2023, v. 17, n. 4, p. 1, doi. 10.1371/journal.pone.0283931
- By:
- Publication type:
- Article
Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 863, doi. 10.1007/s00277-023-05090-z
- By:
- Publication type:
- Article
Two cases of transplant-acquired food allergy who developed resensitization after a negative oral food challenge.
- Published in:
- Allergy, Asthma & Clinical Immunology, 2023, v. 19, n. 1, p. 1, doi. 10.1186/s13223-023-00784-5
- By:
- Publication type:
- Article
Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00804-y
- By:
- Publication type:
- Article
Case report: Genomic analysis of a therapy-related chronic myelomonocytic leukemia with KMT2A rearrangement that progressed to acute myeloid leukemia with acute promyelocytic leukemialike features.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1116418
- By:
- Publication type:
- Article
Recurrent pain attacks during romiplostim treatment in a patient with ITP carrying a heterozygous MEFV mutation.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 2, p. 283, doi. 10.1007/s12185-022-03453-2
- By:
- Publication type:
- Article
A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-022-00768-5
- By:
- Publication type:
- Article
Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00804-y
- By:
- Publication type:
- Article
Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: CARTITUDE‐1 (phase 2) Japanese cohort.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4267, doi. 10.1111/cas.15556
- By:
- Publication type:
- Article
CCR7 alterations associated with inferior outcome of adult T‐cell leukemia/lymphoma under mogamulizumab treatment.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 5, p. 876, doi. 10.1002/hon.3072
- By:
- Publication type:
- Article
A novel RARA–SNX15 fusion in PML–RARA-positive acute promyelocytic leukemia with t(11;17;15)(q13;q21.2;q24.1).
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 6, p. 956, doi. 10.1007/s12185-022-03421-w
- By:
- Publication type:
- Article
Anti-CD38 antibody therapy for patients with relapsed/refractory multiple myeloma: differential mechanisms of action and recent clinical trial outcomes.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105).
- Published in:
- Cancer Science, 2022, v. 113, n. 9, p. 3267, doi. 10.1111/cas.15484
- By:
- Publication type:
- Article
Management of hepatitis B virus (HBV) reactivation in patients with resolved HBV infection based on a highly sensitive HB core‐related antigen assay.
- Published in:
- Hepatology Research, 2022, v. 52, n. 9, p. 745, doi. 10.1111/hepr.13761
- By:
- Publication type:
- Article
MEdical Database AnaLysIS of Japanese multiple myeloma patienTs with apheresis #2 (MEDALIST-2): the impact of plerixafor use on costs and healthcare resources during mobilization and stem cell transplantation.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 3, p. 411, doi. 10.1007/s12185-022-03356-2
- By:
- Publication type:
- Article
Recent advances in the management of older adults with newly diagnosed multiple myeloma in Japan.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 9, p. 966, doi. 10.1093/jjco/hyac111
- By:
- Publication type:
- Article
Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. e751, doi. 10.1016/j.clml.2022.04.005
- By:
- Publication type:
- Article
Pomalidomide, dexamethasone, and daratumumab in Japanese patients with relapsed or refractory multiple myeloma after lenalidomide-based treatment.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 1, p. 122, doi. 10.1007/s12185-022-03338-4
- By:
- Publication type:
- Article
Two‐year outcomes of tirabrutinib monotherapy in Waldenström's macroglobulinemia.
- Published in:
- Cancer Science, 2022, v. 113, n. 6, p. 2085, doi. 10.1111/cas.15344
- By:
- Publication type:
- Article
IRF4 drives clonal evolution and lineage choice in a zebrafish model of T-cell lymphoma.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-30053-9
- By:
- Publication type:
- Article
Safety and Effectiveness of Plerixafor for Peripheral Blood Stem Cell Mobilization in Autologous Stem Cell Transplantation: Results of a Post-Marketing Surveillance Study.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 1, p. 63, doi. 10.1007/s40801-021-00276-1
- By:
- Publication type:
- Article
Clinical significance of the immunoglobulin G heavy‐chain repertoire in peripheral blood mononuclear cells of adult T‐cell leukaemia–lymphoma patients receiving mogamulizumab.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 3, p. 629, doi. 10.1111/bjh.17895
- By:
- Publication type:
- Article
Symptoms and health-related quality of life in patients with newly diagnosed multiple myeloma: a multicenter prospective cohort study.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 2, p. 163, doi. 10.1093/jjco/hyab178
- By:
- Publication type:
- Article
Clinicopathological significance of CD28 overexpression in adult T‐cell leukemia/lymphoma.
- Published in:
- Cancer Science, 2022, v. 113, n. 1, p. 349, doi. 10.1111/cas.15191
- By:
- Publication type:
- Article
A phase 2, open-label, multicenter study of ixazomib plus lenalidomide and dexamethasone in adult Japanese patients with relapsed and/or refractory multiple myeloma.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 224, doi. 10.1007/s10147-021-02030-7
- By:
- Publication type:
- Article
Propensity-score matched analysis of the efficacy of maintenance/continuous therapy in newly diagnosed patients with multiple myeloma: a multicenter retrospective collaborative study of the Japanese Society of Myeloma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 1, p. 191, doi. 10.1007/s00432-021-03668-6
- By:
- Publication type:
- Article
Depletion of central memory CD8<sup>+</sup> T cells might impede the antitumor therapeutic effect of Mogamulizumab.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-27574-0
- By:
- Publication type:
- Article
HLA genotyping in Japanese patients with multiple myeloma receiving bortezomib: An exploratory biomarker study of JCOG1105 (JCOG1105A1).
- Published in:
- Cancer Science, 2021, v. 112, n. 12, p. 5011, doi. 10.1111/cas.15158
- By:
- Publication type:
- Article
Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine.
- Published in:
- Cancer Science, 2021, v. 112, n. 12, p. 5034, doi. 10.1111/cas.15163
- By:
- Publication type:
- Article
Carfilzomib, dexamethasone, and daratumumab in Asian patients with relapsed or refractory multiple myeloma: post hoc subgroup analysis of the phase 3 CANDOR trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Clinical significance of TP53 mutations in adult T‐cell leukemia/lymphoma.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 4, p. 571, doi. 10.1111/bjh.17749
- By:
- Publication type:
- Article
Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. 785, doi. 10.1016/j.clml.2021.06.005
- By:
- Publication type:
- Article
Phase Ib study on the humanized anti-CCR4 antibody, KW-0761, in advanced solid tumors.
- Published in:
- Nagoya Journal of Medical Science, 2021, v. 83, n. 4, p. 827, doi. 10.18999/nagjms.83.4.827
- By:
- Publication type:
- Article
Newly diagnosed follicular lymphoma during pembrolizumab treatment for lung cancer.
- Published in:
- International Journal of Hematology, 2021, v. 114, n. 2, p. 280, doi. 10.1007/s12185-021-03135-5
- By:
- Publication type:
- Article
Pembrolizumab plus pomalidomide and dexamethasone for relapsed or refractory multiple myeloma (KEYNOTE-183): subgroup analysis in Japanese patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A phase I, dose-escalation study of oral PIM447 in Japanese patients with relapsed and/or refractory multiple myeloma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Periplocin and cardiac glycosides suppress the unfolded protein response.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-89074-x
- By:
- Publication type:
- Article